Connect with us

Life Sciences

Aston University wins £1.8m to boost West Midlands low carbon markets

Aston University is to receive £1.8 million to transform the West Midlands into a powerhouse of low-carbon product development and commercialisation….

Published

on

This article was originally published by BioEngineering

Aston University is to receive £1.8 million to transform the West Midlands into a powerhouse of low-carbon product development and commercialisation.

Tim Miller

Credit: Aston University

  • Aston University and local industry to develop technology to convert organic material into commercially valuable products
  • Sawdust, diseased trees and dried chicken litter among what can be transformed into sustainable bioproducts
  • West Midlands companies are invited to join a cluster to develop new low carbon products for growing markets.

Aston University is to receive £1.8 million to transform the West Midlands into a powerhouse of low-carbon product development and commercialisation.

The University will be building on its existing research facilities to lead the region’s Biochar CleanTech Accelerator as part of the West Midlands Innovation Accelerator.

The project was set up with the aim to secure export contracts for low carbon products worth over £200 million, to be made by a regional industrial cluster.

It is hoped that the development of a low-carbon business cluster in the West Midlands will open up new domestic and export markets to help rebuild the region’s engineering and manufacturing status.

Biochar, a sustainable form of charcoal, can be used as a soil and plant growth enhancer. It stores carbon in the ground, so there are fewer greenhouse gases in the atmosphere. Other products such as oils can be used as low carbon fuels for boilers and engines and the liquid by-product can be used for low carbon weedkiller, fungicide and plant growth.

Aston University’s innovative technology is installed at its urban biochar demonstrator in south Birmingham.

The project is based on the strengths of the University’s Energy and Bioproducts Research Institute (EBRI) and its Centre for the Circular Economy and Advanced Sustainability (CEAS).

Tim Miller, director of engagement at EBRI, said: “This new development has the potential to rebuild product development, engineering and manufacturing in our region.

“The project aims to commercialise knowledge, facilities and the results of long-term university research for the benefit of the environment and our regional economy.

“Using the University’s existing expertise and facilities we have the potential to launch new technology-based opportunities as they emerge and mature,

The Biochar CleanTech Accelerator is part of the West Midlands Innovation Accelerator which was first announced in the government’s 2022 Levelling up White Paper and started this spring. It is funded through a share of a £100m from Innovate UK, to be divided by three regional innovation accelerators over the next two years.

Launched by the West Midlands Combined Authority (WMCA) in March 2023, it will target investment on projects enabling new solutions around Medical and Clean Technologies, to further reinforce the region’s position at the frontier of the UK innovation revolution.

The University will also play a key role in two other projects in the West Midlands Innovation Accelerator.

Companies interested in joining the cluster can get further information at https://www.aston.ac.uk/biochar-cleantech-accelerator or emailing biochar@aston.ac.uk




markets

Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending